[Abstract Only] Randomized Trial: Histologic Improvement with Obeticholic Acid in Non-alcoholic Steatohepatitis
9 Dec, 2019 | 01:16h | UTCObeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial – The Lancet (link to abstract – $ for full-text)
“This study is ongoing to assess clinical outcomes.”